drugset / Trial / NCT02663999

A Pharmacokinetic Study to Assess Dose Proportionality, Safety and Tolerability of Diazepam Nasal Spray in Healthy Adult Volunteers

NCT02663999

Phase 1 Completed 15 enrolled Acorda Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

This is a single-center, two-period, randomized, open-label, crossover pharmacokinetic (PK) study in healthy adult volunteers to evaluate dose proportionality of diazepam nasal spray using two dose levels

Timeline

Start
2016-01
Primary completion
2016-04
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule Intranasal

Indications

No indication recorded.